Cargando…
Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s disease
The aim of the present study was to investigate the potential clinical application of the genetic marker microRNA (miRNA)-210 in the cerebrospinal fluid (CSF) and serum of patients with Alzheimer’s disease (AD). The enrolled patients were divided into the mild cognitive impairment (MCI) and AD group...
Autores principales: | ZHU, YAN, LI, CHENGSHAN, SUN, AICHEN, WANG, YUANYE, ZHOU, SHENGNIAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316946/ https://www.ncbi.nlm.nih.gov/pubmed/25667669 http://dx.doi.org/10.3892/etm.2015.2179 |
Ejemplares similares
-
MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study
por: Kopkova, Alena, et al.
Publicado: (2018) -
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023) -
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
por: Gui, YaXing, et al.
Publicado: (2015) -
Synovial Fluid MicroRNA-210 as a Potential Biomarker for Early Prediction of Osteoarthritis
por: Xie, Wen, et al.
Publicado: (2019) -
MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer’s Disease
por: McKeever, Paul M., et al.
Publicado: (2018)